Article Text

other Versions

PDF
Long Term Benefits of Pacing in Obstructive Hypertrophic Cardiomyopathy
  1. Stephen P Page,
  2. Saidi A Mohiddin*
  1. 1 Barts and the London NHS Trust, United Kingdom
  1. Correspondence to: Saidi Mohiddin, Cardiology, London Chest, -6 Sigdon Road, -London, -E8 1AP, United Kingdom; smohiddin{at}doctors.org.uk

Abstract

Therapeutic options for patients with obstructive hypertrophic cardiomyopathy and drug-refractory symptoms include cardiac surgery, percutaneous septal ablation and dual chamber cardiac pacing. Early reports of beneficial haemodynamic and symptomatic effects of ventricular pacing were not supported by results of short-term pacing in randomised studies. More recently, several studies have reported significant and sustained improvements in patient symptoms following long-term pacing. Additionally, the increasing use of pacemaker-defibrillator devices for the primary prevention of sudden death in hypertrophic cardiomyopathy provides an opportunity to attempt a therapeutic trial of pacing in appropriate cases. In this context, we review the role of pacing in hypertrophic cardiomyopathy.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles